Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1989 Jul;52(7):891–894. doi: 10.1136/jnnp.52.7.891

The significance of plasma phytanic acid levels in adults.

T C Britton 1, F B Gibberd 1, M E Clemens 1, J D Billimoria 1, M C Sidey 1
PMCID: PMC1031939  PMID: 2475586

Abstract

The presence of phytanic acid in tissues and plasma has been considered diagnostic of heredopathia atactica polyneuritiformis (Refsum's disease), but recently slightly raised plasma phytanic acid levels have been reported in other conditions. Forty two normal people were found to have a phytanic acid level of 0-33 mumol/l. Fourteen patients with heredopathia atactica polyneuritiformis had a plasma phytanic acid level before treatment of 992-6400 mumol/l. Five patients with retinitis pigmentosa but not heredopathia atactica polyneuritiformis had plasma levels of 38-192 mumol/l. It was concluded that some patients with retinitis pigmentosa without heredopathia atactica polyneuritiformis but a raised plasma phytanic acid may represent a group of patients with a disease or diseases as yet uncharacterised apart from the retinal condition.

Full text

PDF
891

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avigan J. The presence of phytanic acid in normal human and animal plasma. Biochim Biophys Acta. 1966 Apr 4;116(2):391–394. doi: 10.1016/0005-2760(66)90022-1. [DOI] [PubMed] [Google Scholar]
  2. BURSTEIN M., SAMAILLE J. [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins]. Clin Chim Acta. 1960 Jul;5:609–609. doi: 10.1016/0009-8981(60)90075-9. [DOI] [PubMed] [Google Scholar]
  3. Budden S. S., Kennaway N. G., Buist N. R., Poulos A., Weleber R. G. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr. 1986 Jan;108(1):33–39. doi: 10.1016/s0022-3476(86)80765-x. [DOI] [PubMed] [Google Scholar]
  4. Dotti M. T., Rossi A., Rizzuto N., Hayek G., Bardelli N., Bardelli A. M., Federico A. Atypical phenotype of Refsum's disease: clinical, biochemical, neurophysiological and pathological study. Eur Neurol. 1985;24(2):85–93. doi: 10.1159/000115767. [DOI] [PubMed] [Google Scholar]
  5. Gibberd F. B., Billimoria J. D., Goldman J. M., Clemens M. E., Evans R., Whitelaw M. N., Retsas S., Sherratt R. M. Heredopathia atactica polyneuritiformis: Refsum's disease. Acta Neurol Scand. 1985 Jul;72(1):1–17. doi: 10.1111/j.1600-0404.1985.tb01541.x. [DOI] [PubMed] [Google Scholar]
  6. Gibberd F. B., Billimoria J. D., Page N. G., Retsas S. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange. Lancet. 1979 Mar 17;1(8116):575–578. doi: 10.1016/s0140-6736(79)91005-5. [DOI] [PubMed] [Google Scholar]
  7. KLENK E., KAHIKE W. UBER DAS VORKOMMEN DER 3.7.11.15-TETRAMETHYL-HEXADECANSAEURE (PHYTANSAEURE) IN DEN CHOLESTERINESTERN UND ANDEREN LIPOIDFRAKTIONEN DER ORGANE BEI EINEM KRANKHEITSFALL UN- BEKANNTER GENESE (VERDACHT AUF HEREDOPATHIA ATACTICA POLYNEURITIFORMIS. Hoppe Seylers Z Physiol Chem. 1963;333:133–139. doi: 10.1515/bchm2.1963.333.1.133. [DOI] [PubMed] [Google Scholar]
  8. KREMER G. J. UBER DAS VORKOMMEN DER 3,7,11,15-TETRAMETHYLHEXADECANSAEURE IN DEN LIPOIDEN VON NORMALSEREN. Klin Wochenschr. 1965 May 1;43:517–518. doi: 10.1007/BF01486095. [DOI] [PubMed] [Google Scholar]
  9. Masters-Thomas A., Bailes J., Billimoria J. D., Clemens M. E., Gibberd F. B., Page N. G. Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management. J Hum Nutr. 1980 Aug;34(4):245–250. doi: 10.3109/09637488009143444. [DOI] [PubMed] [Google Scholar]
  10. Moser H. W. Peroxisomal disorders. J Pediatr. 1986 Jan;108(1):89–91. doi: 10.1016/s0022-3476(86)80774-0. [DOI] [PubMed] [Google Scholar]
  11. Poulos A. Diagnosis of Refsum's disease using [1-14C]phytanic acid as substrate. Clin Genet. 1981 Oct;20(4):247–253. doi: 10.1111/j.1399-0004.1981.tb01029.x. [DOI] [PubMed] [Google Scholar]
  12. Poulos A., Pollard A. C., Mitchell J. D., Wise G., Mortimer G. Patterns of Refsum's disease. Phytanic acid oxidase deficiency. Arch Dis Child. 1984 Mar;59(3):222–229. doi: 10.1136/adc.59.3.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Poulos A., Sharp P., Whiting M. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome? Clin Genet. 1984 Dec;26(6):579–586. doi: 10.1111/j.1399-0004.1984.tb01107.x. [DOI] [PubMed] [Google Scholar]
  14. Skjeldal O. H., Stokke O., Refsum S., Norseth J., Petit H. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation. J Neurol Sci. 1987 Jan;77(1):87–96. doi: 10.1016/0022-510x(87)90209-7. [DOI] [PubMed] [Google Scholar]
  15. Stokke O., Try K., Eldjarn L. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease. Biochim Biophys Acta. 1967 Oct 2;144(2):271–284. doi: 10.1016/0005-2760(67)90157-9. [DOI] [PubMed] [Google Scholar]
  16. Weleber R. G., Tongue A. C., Kennaway N. G., Budden S. S., Buist N. R. Ophthalmic manifestations of infantile phytanic acid storage disease. Arch Ophthalmol. 1984 Sep;102(9):1317–1321. doi: 10.1001/archopht.1984.01040031067026. [DOI] [PubMed] [Google Scholar]
  17. van Eck J. H., Woldring M. G. Scanning the brain with various radioisotopes. Manual and automatic studies in a series of 750 patients. Eur Neurol. 1969;2(1):1–12. doi: 10.1159/000113769. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES